Haemonetics Corporation (FRA:HAZ)

Market Cap	3.30B
Revenue (ttm)	1.14B
Net Income (ttm)	143.84M
Shares Out	n/a
EPS (ttm)	2.94
PE Ratio	22.95
Forward PE	15.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	21
Open	71.00
Previous Close	72.00
Day's Range	70.00 - 73.50
52-Week Range	39.80 - 76.50
Beta	n/a
RSI	59.77
Earnings Date	Feb 5, 2026

About Haemonetics

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools....

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1971
• Employees: 3,023
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HAZ

Financial Performance

In 2024, Haemonetics's revenue was $1.36 billion, an increase of 3.95% compared to the previous year's $1.31 billion. Earnings were $167.68 million, an increase of 42.64%.

Financial numbers in USD